title: Baseline heart rate-corrected QT and eligibility for clinical trials in oncology.
authors.forename: Mary
authors.initials: M
authors.lastname: Varterasian
authors.forename: Mark
authors.initials: M
authors.lastname: Meyer
authors.forename: Howard
authors.initials: H
authors.lastname: Fingert
authors.forename: Diane
authors.initials: D
authors.lastname: Radlowski
authors.forename: Peggy
authors.initials: P
authors.lastname: Asbury
authors.forename: Xiaofeng
authors.initials: X
authors.lastname: Zhou
authors.forename: Diane
authors.initials: D
authors.lastname: Healey
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004452:Echocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D018579:Patient Selection; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents